Skip to main content
. 2023 Dec 1;8(49):47239–47253. doi: 10.1021/acsomega.3c07434

Figure 2.

Figure 2

Antiproliferative activities of the synthesized compounds against doxorubicin (Dox.) [x-axis: compounds under investigation; y-axis: IC50 values (μM)].